|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
|
Case ID: 2000 | Drugs / Medical | 02/27/2003
Kahn Gauthier Swick is investigating possible legal actions against Amarin Pharmaceuticals, Inc., the manufacturer of the prescription drug Permax (pergolide mesylate), to recover for heart damage suffered by some patients taking the drug. Permax is prescribed for patients suffering from Parkinson's disease, a neurological disorder that causes shaking, freezing, and other movement disorders. Concern over Permax has risen since the publication of an article in the December, 2002, issue of the medical journal Mayo Clinic Proceedings that revealed three cases of heart valve disease in patients taking Permax.
While the evidence in the report is based only on three cases treated at the Mayo Clinic, the doctors who wrote the report say their evidence is enough to recommend that anyone with heart problems not take Permax, which has been used since 1989. In the cases that were treated at the clinic, three older women--aged 61, 72, and 74--had been taking various doses of Permax daily for between three and seven years to treat their Parkinson's disease. At the clinic they were diagnosed with serious heart valve disease; two had to have valve replacement surgery. None of the three had a prior history of heart disease. Valvular heart disease is a condition that impairs heart function. The heart functions as a one-way pump to move blood through the lungs and the body. Within the heart, valves work to prevent the backward flow of blood in the heart. In patients with valvular heart disease, one or more of these valves fails to seal properly and allows significant amounts of blood to flow backwards, or regurgitate. Valvular regurgitation increases the workload on the heart and, in sufficiently severe cases, can require heart valve replacement surgery. Left unchecked and untreated, some types of valvular heart disease can progress to the point where the patient is at risk of death from heart failure. Permax shares characteristics with a number of other drugs that have been associated with valvular heart disease. These drugs, including the now-banned fen-phen combination, are all associated with a heightened stimulation of serotonin receptors, and one of the doctors who wrote the new report speculates that this mechanism could somehow cause the valve damage. Parkinson's disease is a progressive neurological disorder resulting from the degeneration of neurons in a region of the brain that controls movement. The degeneration creates a shortage of the brain-signaling chemical known as dopamine, causing the movement impairments that characterize the disease. In the United States, at least 500,000 people are believed to suffer from Parkinson's disease, and about 50,000 new cases are reported annually, according to the National Institute of Neurological Disorders and Stroke. Other Side EffectsThe following side effects may be linked to Permax use: Body as a Whole - Frequent: headache asthenia, accidental injury, pain, abdominal pain, chest pain, back pain, flu syndrome, neck pain, fever; Infrequent: facial edema, chills, enlarged abdomen, malaise, neoplasm, hernia, pelvic pain, sepsis, cellulitis, moniliasis, abscess, jaw pain, hypothermia; Rare: acute abdominal syndrome, LE syndrome. Cardiovascular System - Frequent: postural hypotension, syncope, hypertension, palpitations, vasodilatations, congestive heart failure; Infrequent: myocardial infarction, tachycardia, heart arrest, abnormal electrocardiogram, angina pectoris, thrombophlebitis, bradycardia, ventricular extrasystoles, cerebrovascular accident, ventricular tachycardia, cerebral ischemia, atrial fibrillation, varicose vein, pulmonary embolus, AV block, shock; Rare: vasculitis, pulmonary hypertension, pericarditis, migraine, heart block, cerebral hemorrhage. Digestive System - Frequent: nausea, vomiting, dyspepsia, diarrhea, constipation, dry mouth, dysphagia; Infrequent: flatulence, abnormal liver function tests, increased appetite, salivary gland enlargement, thirst, gastroenteritis, gastritis, periodontal abscess, intestinal obstruction, nausea and vomiting, gingivitis, esophagitis, cholelithiasis, tooth caries, hepatitis, stomach ulcer, melena, hepatomegaly, hematemesis, eructation; Rare: sialadenitis, peptic ulcer, pancreatitis, jaundice, glossitis, fecal incontinence, duodenitis, colitis, cholecystitis, aphthous stomatitis, esophageal ulcer. Endocrine System - Infrequent: hypothyroidism, adenoma, diabetes mellitus, ADH inappropriate; Rare: endocrine disorder, thyroid adenoma. Hemic and Lymphatic System - Frequent: anemia; Infrequent: leukopenia, lymphadenopathy, leukocytosis, thrombocytopenia, petechia, megaloblastic anemia, cyanosis; Rare: purpura, lymphocytosis, eosinophilia, thrombocythemia, acute lymphoplastic leukemia, polycythemia, splenomegaly. Metabolic and Nutritional System - Frequent: peripheral edema, weight loss, weight gain; Infrequent: dehydration, hypokalemia, hypoglycemia, iron deficiency anemia, hyperglycemia, gout, hyper-cholesteremia; Rare: electrolyte imbalance, cachexia, acidosis, hyperuricemia. Musculoskeletal System - Frequent: twitching, myalgia, arthralgia; Infrequent: bone pain, tenosynovitis, myositis, bone sarcoma, arthritis; Rare: osteoporosis, muscle atrophy, osteomyelitis. Nervous System - Frequent: dyskinesia, dizziness, hallucinations, confusion, somnolence, insomnia, dystonia, paresthesia, depression, anxiety, tremor, akinesia, extrapyramidal syndrome, abnormal gait, abnormal dreams, incoordination, psychosis, personality disorder, nervousness, choreoathetosis, amnesia, paranoid reaction, abnormal thinking; Infrequent: akathisia, neuropathy, neuralgia, hypertonia, delusions, convulsion, libido increased, euphoria, emotional lability, libido decreased, vertigo, myoclonus, coma, apathy, paralysis, neurosis, hyperkinesia, ataxia, acute brain syndrome, torticollis, meningitis, manic reaction, hypokinesia, hostility, agitation, hypotonia; Rare: stupor, neuritis, intracranial hypertension, hemiplegia, facial paralysis, brain edema, myelitis, hallucinations and confusion after abrupt discontinuation. Respiratory System - Frequent: rhinitis, dyspnea, pneumonia, pharyngitis, cough increased; Infrequent: epistaxis, hiccup, sinusitis, bronchitis, voice alteration, hemoptysis, asthma, lung edema, pleural effusion, laryngitis, emphysema, apnea, hyperventilation; Rare: pneumothorax, lung fibrosis, larynx edema, hypoxia, hypoventilation, hemothorax, carcinoma of lung. Skin and Appendages System - Frequent: sweating, rash; Infrequent: skin discoloration, pruritus, acne, skin ulcer, alopecia, dry skin, skin carcinoma, seborrhea, hirsutism, herpes simplex, eczema, fungal dermatitis, herpes zoster; Rare: vesiculobullous rash, subcutaneous nodule, skin nodule, skin benign neoplasm, lichenoid dermatitis. Special Senses System - Frequent: abnormal vision, diplopia; Infrequent: otitis media, conjunctivitis, tinnitus, deafness, taste perversion, ear pain, eye pain, glaucoma, eye hemorrhage, photophobia, visual field defect; Rare: blindness, cataract, retinal detachment, retinal vascular disorder. Urogenital System - Frequent: urinary tract infection, urinary frequency, urinary incontinence, hematuria, dysmenorrhea; Infrequent: dysuria, breast pain, menorrhagia, impotence, cystitis, urinary retention, abortion, vaginal hemorrhage, vaginitis, priapism, kidney calculus, fibrocystic breast, lactation, uterine hemorrhage, urolithiasis, salpingitis, pyuria, metrorrhagia, menopause, kidney failure, breast carcinoma, cervical carcinoma; Rare: amenorrhea, bladder carcinoma, breast engorgement, epididymitis, hypogonadism, leukorrhea, nephrosis, pyelonephritis, urethral pain, uricaciduria, withdrawal bleeding. Register your Amarin Pharmaceuticals Permax ComplaintIf you or someone you know has been affected by this case, you may qualify for a money settlement as the result of your financial/economic or other damages that may be awarded either prior to a lawsuit or after the initiation of a lawsuit either currently in progress or filed just for you, possibly a class action lawsuit. Please simply register your complaint by clicking here for Amarin Pharmaceuticals Permax, or click the red "submit" button on this page, and a lawyer will review your Amarin Pharmaceuticals Permax complaint. By submitting your complaint, you are asking lawyers to contact you. You are under no obligation to accept their services and you are free to choose which lawyer you want to work with. Lawyers are usually paid out of the proceeds of the settlement or verdict rendered - the lawyers work on "contingency" by fronting the costs of your lawsuit based on their belief that they will recover a settlement for you. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest Kahn Gauthier Swick is investigating possible legal actions against Eli Lilly and Company, the manufacturer of the prescription drug Zyprexa (olanzapine), on behalf of patients prescribed Zyprexa who have developed diabetes, hyperglycemia (elevated blood sugar), and other blood sugar disorders as a result of the drug. A recent $690 million dollar settlement has been announced for certain Zyprexa claimants.
Judgment has been entered against United HealthCare Services, Inc. and its insurer-sibling HealthCare Insurance Company on behalf of participants in pharmacy benefit plans governed by the federal Employee Retirement Income Security Act and administered by United. The action asks United to provide reimbursement for drug overcharges that occurred when the plan administrator failed to pass on its negotiated prices to participants. Monetary damages will not be distributed until all proceedings have been finalized and all possible appeals have been exhausted. A class action has been filed against Madisonville, Kentucky’s Trover Regional Medical Center, on behalf of thousands of patients going back a decade or more, who allege that their medical films were misread, overlooking potentially serious conditions, including cancer. A class action has been filed against Watson Pharmaceuticals Inc. (NYSE: WPI) and certain of its officers and directors by stockholders who purchased the company's common stock between November 2, 1999, and November 13, 2001. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. Kahn Gauthier Swick is investigating possible legal actions against Boehringer Ingelheim Pharmaceuticals, Inc., the German pharmaceutical and chemical conglomerate, after it issued new warnings regarding its HIV drug Nevirapine (trade name Viramune) in February 2004. The new warnings indicate that the drug can cause severe, life-threatening toxicity in patients’ livers, possibly culminating in complete hepatic failure. These events are often associated with a rash that can sometimes become life-threatening in and of itself. If you or one of your loved ones has suffered such reactions or passed away due to one, please contact Kahn Gauthier for a consultation. A nationwide class action has been filed against the manufacturer of weight-loss supplement CortiSlim, Window Rock Health Laboratories, Inc., on behalf of all purchasers of the supplement, who allege that the company has used false, deceptive, and misleading advertising to sell its products in violation of California consumer protection laws. |
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.









